通產麗星(002243.SZ):收到獲核發的廣州市麗星材料科技有限公司營業執照
格隆匯5月20日丨通產麗星(002243.SZ)公佈,公司於2020年4月22日召開第五屆董事會第五次會議,審議通過了《關於在廣州市白雲區投資建設研發生產基地的議案》,同意公司全資子公司深圳市通產麗星科技集團有限公司以自籌資金4億元在廣州市白雲區投資建設高端化粧品研發生產總部基地,並設立廣州市麗星包裝科技有限公司(暫定名)負責項目地塊競買及項目實施工作。
近日,公司收到廣州市白雲區市場監督管理局核發的廣州市麗星材料科技有限公司營業執照,其一般經營範圍:包裝裝潢設計服務;模具製造;材料科學研究、技術開發;塑料包裝箱及容器製造;化粧品技術開發;化粧品製造;生物分解塑料製品製造;貨物進出口(專營專控商品除外);商品批發貿易(許可審批類商品除外);項目投資(不含許可經營項目,法律法規禁止經營的項目不得經營);物業管理;房屋租賃。
許可經營範圍:衞生材料及醫藥用品製造;消毒劑製造;醫用電子儀器設備的生產(具體生產範圍以《醫療器械生產企業許可證》為準);包裝裝潢印刷品印刷;除出版物、包裝裝潢印刷品之外的其他印刷品印刷;道路貨物運輸。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.